FTSE 100
9.760,06
PKT
+3,92
PKT
+0,04
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.10.25 | Shell (ex Royal Dutch Shell) Kaufen | DZ BANK | |
| 30.10.25 | GSK Halten | DZ BANK | |
| 30.10.25 | Rio Tinto Neutral | UBS AG | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 30.10.25 | GSK Hold | Deutsche Bank AG | |
| 30.10.25 | GSK Neutral | UBS AG | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.10.25 | HSBC Sector Perform | RBC Capital Markets | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 29.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 29.10.25 | HSBC Hold | Deutsche Bank AG | |
| 29.10.25 | GSK Outperform | Bernstein Research | |
| 29.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 29.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.10.25 | HSBC Overweight | Barclays Capital | |
| 28.10.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.10.25 | HSBC Neutral | UBS AG | |
| 28.10.25 | HSBC Sector Perform | RBC Capital Markets | |
| 28.10.25 | HSBC Overweight | Barclays Capital | |
| 28.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 28.10.25 | HSBC Hold | Jefferies & Company Inc. | |
| 27.10.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 27.10.25 | Glencore Neutral | JP Morgan Chase & Co. | |
| 27.10.25 | Unilever Kaufen | DZ BANK | |
| 27.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 27.10.25 | GSK Hold | Deutsche Bank AG | |
| 27.10.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 27.10.25 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 27.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 27.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.10.25 | Unilever Underperform | RBC Capital Markets | |
| 24.10.25 | RELX Hold | Deutsche Bank AG | |
| 24.10.25 | Unilever Buy | Deutsche Bank AG | |
| 24.10.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 24.10.25 | GSK Neutral | UBS AG | |
| 24.10.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 24.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.10.25 | Unilever Sell | UBS AG | |
| 24.10.25 | Unilever Neutral | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.